Photo detail

Katie Szyman

Stories this photo appears in:

Edwards Looks Ahead

Edwards Lifesciences Corp. (NYSE: EW) recently got FDA approval of its ForeSight tissue oximetry device.

Tease photo

Edwards Makes $100M Acquisition

CAS Medical’s technology “provides an important indicator of oxygen levels in the brain, which can enhance clinician decision-making,” said Katie Szyman, Edwards' corporate vice president, critical care, in a statement.

Tease photo